Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...

Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance ...

With the sales of weight-loss drugs booming, India is now the epicentre of the global obesity treatment market, reports The ...

A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...